Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms. [electronic resource] by
- Pazina, Tatiana
- James, Ashley M
- MacFarlane, Alexander W
- Bezman, Natalie A
- Henning, Karla A
- Bee, Christine
- Graziano, Robert F
- Robbins, Michael D
- Cohen, Adam D
- Campbell, Kerry S
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 6
Availability: No items available.
|
|
|
4.
|
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models. [electronic resource] by
- Bezman, Natalie A
- Jhatakia, Amy
- Kearney, Alper Y
- Brender, Ty
- Maurer, Mark
- Henning, Karla
- Jenkins, Misty R
- Rogers, Amy J
- Neeson, Paul J
- Korman, Alan J
- Robbins, Michael D
- Graziano, Robert F
Publication details: Blood advances May 2017
In:
Blood advances vol. 1
Availability: No items available.
|
|
|
5.
|
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. [electronic resource] by
- Pazina, Tatiana
- James, Ashley M
- Colby, Kimberly B
- Yang, Yibin
- Gale, Andrew
- Jhatakia, Amy
- Kearney, Alper Y
- Graziano, Robert F
- Bezman, Natalie A
- Robbins, Michael D
- Cohen, Adam D
- Campbell, Kerry S
Producer: 20200924
In:
Cancer immunology research vol. 7
Availability: No items available.
|
|
|
6.
|
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened. [electronic resource] by
- Munchhof, Michael J
- Li, Qifang
- Shavnya, Andrei
- Borzillo, Gary V
- Boyden, Tracey L
- Jones, Christopher S
- LaGreca, Susan D
- Martinez-Alsina, Luis
- Patel, Nandini
- Pelletier, Kathleen
- Reiter, Larry A
- Robbins, Michael D
- Tkalcevic, George T
Producer: 20140605
In:
ACS medicinal chemistry letters vol. 3
Availability: No items available.
|
|
|
7.
|
Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. [electronic resource] by
- Hawkins, Julie L
- Robbins, Michael D
- Warren, Laurie C
- Xia, Donghui
- Petras, Stephen F
- Valentine, James J
- Varghese, Alison H
- Wang, Ing-Kae
- Subashi, Timothy A
- Shelly, Lorraine D
- Hay, Bruce A
- Landschulz, Katherine T
- Geoghegan, Kieran F
- Harwood, H James
Producer: 20080929
In:
The Journal of pharmacology and experimental therapeutics vol. 326
Availability: No items available.
|
|
|
8.
|
Aminopyrrolidineamide inhibitors of site-1 protease. [electronic resource] by
- Hay, Bruce A
- Abrams, Barbara
- Zumbrunn, Allice Y
- Valentine, James J
- Warren, Laurie C
- Petras, Stephen F
- Shelly, Lorraine D
- Xia, Angela
- Varghese, Alison H
- Hawkins, Julie L
- Van Camp, Jennifer A
- Robbins, Michael D
- Landschulz, Katherine
- Harwood, H James
Producer: 20071121
In:
Bioorganic & medicinal chemistry letters vol. 17
Availability: No items available.
|
|
|
9.
|
Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab. [electronic resource] by
- Kurdi, Ahmed T
- Glavey, Siobhan V
- Bezman, Natalie A
- Jhatakia, Amy
- Guerriero, Jennifer L
- Manier, Salomon
- Moschetta, Michele
- Mishima, Yuji
- Roccaro, Aldo
- Detappe, Alexandre
- Liu, Chia-Jen
- Sacco, Antonio
- Huynh, Daisy
- Tai, Yu-Tzu
- Robbins, Michael D
- Azzi, Jamil
- Ghobrial, Irene M
Producer: 20190722
In:
Molecular cancer therapeutics vol. 17
Availability: No items available.
|
|
|
10.
|
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma. [electronic resource] by
- Ghobrial, Irene M
- Liu, Chia-Jen
- Redd, Robert A
- Perez, Raymond P
- Baz, Rachid
- Zavidij, Oksana
- Sklavenitis-Pistofidis, Romanos
- Richardson, Paul G
- Anderson, Kenneth C
- Laubach, Jacob
- Henrick, Patrick
- Savell, Alexandra
- Reyes, Kaitlen
- Hornburg, Kalvis
- Chuma, Stacey
- Sabbatini, Peter
- Robbins, Michael D
- Becker, Pamela S
Producer: 20201001
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
11.
|
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications. [electronic resource] by
- Anderson, Kenneth C
- Auclair, Daniel
- Kelloff, Gary J
- Sigman, Caroline C
- Avet-Loiseau, Hervé
- Farrell, Ann T
- Gormley, Nicole J
- Kumar, Shaji K
- Landgren, Ola
- Munshi, Nikhil C
- Cavo, Michele
- Davies, Faith E
- Di Bacco, Alessandra
- Dickey, Jennifer S
- Gutman, Steven I
- Higley, Howard R
- Hussein, Mohamad A
- Jessup, J Milburn
- Kirsch, Ilan R
- Little, Richard F
- Loberg, Robert D
- Lohr, Jens G
- Mukundan, Lata
- Omel, James L
- Pugh, Trevor J
- Reaman, Gregory H
- Robbins, Michael D
- Sasser, A Kate
- Valente, Nancy
- Zamagni, Elena
Producer: 20180423
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|